AbbVie is a large biopharmaceutical company that researches, makes, and sells prescription medicines. Its lobbying filings show it works on health-related policies, including patient access, pharmaceutical manufacturing, patent reform, and drug pricing and Medicare drug reimbursement. AbbVie also lobbied on tariff rules (reciprocal tariffs) and direct-to-consumer advertising.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ADAM STEINMETZ
The latest disclosures for this client.
BROWNSTEIN HYATT FARBER SCHRECK, LLP
Q2BROWNSTEIN HYATT FARBER SCHRECK, LLP
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
BROWNSTEIN HYATT FARBER SCHRECK, LLP
ALFRED MOTTUR
BROWNSTEIN HYATT FARBER SCHRECK, LLP
DEEMA TARAZI
BROWNSTEIN HYATT FARBER SCHRECK, LLP
EMILY FELDER
BROWNSTEIN HYATT FARBER SCHRECK, LLP
ms ELIZABETH ANNE MAIER
BROWNSTEIN HYATT FARBER SCHRECK, LLP
ms LAUREN ALEXANDRA MISH
BROWNSTEIN HYATT FARBER SCHRECK, LLP
ZACHARY PFISTER
BROWNSTEIN HYATT FARBER SCHRECK, LLP
mr JOSEPH BRADY HOWELL
BROWNSTEIN HYATT FARBER SCHRECK, LLP
BROWNSTEIN HYATT FARBER SCHRECK, LLP
Q4BROWNSTEIN HYATT FARBER SCHRECK, LLP
Q3BROWNSTEIN HYATT FARBER SCHRECK, LLP
Q2BROWNSTEIN HYATT FARBER SCHRECK, LLP
1ABROWNSTEIN HYATT FARBER SCHRECK, LLP
Q1